🇺🇸 FDA
Pipeline program

Cordyceps cicadae extract

CRREC-111-087

Phase 1 mab completed

Quick answer

Cordyceps cicadae extract for Myopia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Myopia
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials